12.77
2.82%
+0.35
Mineralys Therapeutics Inc (MLYS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - |
Operating Expenses
|
5.47%
27.71
|
26.27 | 15.73 | 14.94 |
Operating Income/Loss |
5.47%
-27.71
|
-26.27 | -15.73 | -14.94 |
Nonoperating Income/Loss |
5.44%
3.322
|
3.513 | 3.594 | 2.33 |
Income/Loss From Continuing Operations Before Tax |
7.16%
-24.39
|
-22.76 | -12.14 | -12.61 |
Income/Loss From Continuing Operations After Tax |
7.16%
-24.39
|
-22.76 | -12.14 | -12.61 |
Net Income/Loss
|
7.16%
-24.39
|
-22.76 | -12.14 | -12.61 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - |
Basic Average Shares |
96.70%
1.316
|
39.93 | 39.75 | 24.76 |
Diluted Average Shares |
96.70%
1.316
|
39.93 | 39.75 | 24.76 |
Basic Earnings Per Share |
10.53%
-0.63
|
-0.57 | -0.31 | -0.51 |
Diluted Earnings Per Share |
10.53%
-0.63
|
-0.57 | -0.31 | -0.51 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
자본화:
|
볼륨(24시간):